|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from financial institutions | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Time deposits in banks | ||||||||||||||||||||
| Securities available-for-sale, at fair value, net of allowance for credit losses of $0 at June 30, 2026 and December 31, 2025 (amortized cost of $103,308 and $107,197 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost, net of allowance for credit losses of $20 at June 30, 2026 and December 31, 2025 (fair value of $1,927 and $1,995 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans held for investment, net of allowance for credit losses | ||||||||||||||||||||
| Federal Home Loan Bank of San Francisco (“FHLB”) stock | ||||||||||||||||||||
| Operating leases, right-of-use asset, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance, net | ||||||||||||||||||||
| Interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Subordinated notes, net | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value; 10,000,000 shares authorized; zero issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Common stock, no par value; 100,000,000 shares authorized; 21,402,864 shares issued and outstanding at June 30, 2026; 21,367,387 shares issued and outstanding at December 31, 2025 | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of taxes | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...